维普中文期刊产品整合服务
10篇 您的检索式:作者名="Reckamp K L"
    题名 作者 年代 出处 被引量
1Non-small cell lung cancer in the elderly: defining treatment options显示文摘Vora N Reckamp K L 2008Semin Oncol2008,35,6:1
2The potential and rational for COX-2 inhibitors in lung cancer显示文摘Krysan K Reckamp K L Sharma S 2006Anticancer Agents Med Chem2006,6,3:1
3Non - small cell lung cancer In the eld- erly defining treatment options 显示文摘Vora N Reckamp K L 2008Sere in Oncol2008,35,:1
4The potential and rational for C)X-2 inhibitors in Lung cancer显示文摘Krysan K Reckamp K L Sharma S 2006Anticancer Agents Med Chert2006,6,3:1
5CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer显示文摘Reckamp K L Figlin R A Burdick M D 2009BMC Cancer2009,9,:1
6The role of targeting mare-malian target of rapamycin in lung cancer显示文摘Pal S K Figlin R A Reckamp K L 2008Clin Lung Cancer2008,9,6:1
7Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin 显示文摘RECKAMP K L GARDNER B K FIGLIN R A 2008J Thorac Oncol2008,3,2:1
8Randomized phase 2 trial of erlotinib in combination with high-dose celecox- ib or placebo in patients with advanced non-small cell lung cancer显示文摘Reckamp K L Koczywas M Cristea M C 2015Cancer2015,121,18:1
9Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner显示文摘Krysan K Reckamp K L Dalwadi H 2005Cancer Res2005,1565,:1
10Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer显示文摘Brahmer J Reckamp K L Baas P 2015N Engl J Med2015,373,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费